Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: WWS who wrote (1035)	1/8/1998 7:40:00 PM
From: EZLibra	Read Replies (1) \| Respond to of 3702

Nope, no favors there. The thread should pick up by now that Lon is not good at sales (opening his mouth would help). McCamant and Lon met years ago and it was a no go. In Lon's defense I have also met McCamant and he is not pleasant. In Worth magazine he is a regular who flogs one of his 20 dogs every month. Immunogen doesn't belong in the same textbook as TCLN. It's just January (open your mouth, Lon) but IMGN is out of Harvard and does have an interesting chart, we'll see how long the compression blowoff lasts. McCamant, Barrons, brokerages, money managers, etc. only tout what they hope you, John Q. Public, will buy enough of so they can sell it to you. I forget if McCamant has been touting IMGN since it was 8 or 15 but it has been a long time. Their technology is maybe a tenth of TCLN's. But they do have a McCamant.